invention. Neither amendment introduces new matter into
the application.
9. The specification, as filed, states (page 4,
lines 3-6):
Examples of suitable blocking agents that may be used
include butanone oxime, diisopropylamine, 1,2,4-triazole,
imidazole, malonic ester, acetoacetic ester, dimethyl
pyrazole, ,-caprolactam, and mixtures thereof. Butanone
oxime is particularly preferred.
10. Example 1 of applicants' specification, as
filed, describes the use of the blocking agent butanone oxime
(page 6).
11. Upon consideration of the amendment to claim 1,
the examiner withdrew the anticipation rejection based on Gras
and entered a final rejection of claims 1-5 under the first
paragraph of 35 U.S.C. § 112 finding that applicants'
specification, as filed, does not describe the invention of
amended claim 1 (Paper 9, page 2).
12. The examiner also finally rejected claims 1-5 as
being unpatentable for obviousness based on Cook or Konig in
view of Uhrhan (Paper 9, pages 3-5).
- 5 -
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next
Last modified: November 3, 2007